Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing



Rating:

Share or cite this content

Citations should be made in the following way:
K. Bergmann (Berlin, Germany), T. Zuberbier (Berlin, Germany). Obstructive sleep apnoe improves on Dupilumab in patients treated for polyposis and severe asthma. 752

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients. Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019 Presence of sleep apnea syndrome in the group of severe and very severe COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 198s Year: 2006 Obstructive sleep apnea syndrome as a cause of uncontrolled nocturnal asthma Source: Eur Respir J 2004; 24: Suppl. 48, 114s Year: 2004 Treatment control in risk patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 411s Year: 2006 Airway inflammation in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002 Prevalence of obstructive sleep apnea in patients with difficult-to-treat asthma Source: Annual Congress 2011 - Asthma: risk factors and comorbidities Year: 2011 Associated pathologies and tobacco habit in patients diagnosed of obstructive sleep apnoea syndrome treated with nCPAP Source: Eur Respir J 2002; 20: Suppl. 38, 451s Year: 2002 The symptom prevalence of obstructive sleep apnea syndrome in patients with asthma and COPD Source: Eur Respir J 2006; 28: Suppl. 50, 198s Year: 2006 Low prevalence of obstructive sleep apnoea in paediatric severe therapy resistant asthma Source: International Congress 2019 – Asthma education: lifestyle and adolescence Year: 2019 Assessment of the prevalence of obstructive sleep apnea in patients with undiagnosed chronic cough Source: Annual Congress 2012 - Sleep disorders in internal medicine Year: 2012 Metabolic syndrome in moderate to severe obstructive sleep apnea? Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020 The prevalence of unrecognized obstructive sleep apnea syndrome among patients with nocturnal symptoms and poorly controlled asthma Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017 Laryngeal obstruction in moderate and severe obstructive sleep apnea patients requested higher CPAP level during treatments Source: International Congress 2018 – Sleep and breathing control: phenotypes Year: 2018 Investigation of the prevalence of obstructive sleep apnea syndrome in patients with diagnosed subclinicalhypothyroidism Source: Sleep and Breathing Conference 2021 Year: 2021 High flow-nasal cannula oxygen treatment in patients with concomitant severe chronic obstructive pulmonary diseases and mild-moderate  sleep apnea  (overlap syndrome). Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Influence of electrostimulation of pharyngeal and laryngeal muscles in complex with traditional treatment of COPD on functional signs of obstructive sleep apnea syndrome in patients with combined pathology – obstructive sleep apnea syndrome + COPD Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Association between severe obstructive sleep apnea syndrome and sinus dysfunction Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Chronic respiratory failure in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005 Roles of periostin in patients with severe obstructive sleep apnea Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017 Secondary hypogonadism induced by severe obstructive sleep apnea syndrome (OSAS) and results after two months CPAP treatment Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010